infoVAXX

Publications

Report on the effectiveness of vaccination against COVID-19 in Luxembourg (French, Pdf, 3.60 Mb)

Report on the effectiveness of vaccination against COVID-19 in Luxembourg (Update - 16 December 2021) (French, Pdf, 1.04 Mb)

Second Report on the effectiveness of vaccination against COVID-19 in Luxembourg (16.05.2022) (French, Pdf, 4.35 Mb)

Second Report on the effectiveness of vaccination against COVID-19 in Luxembourg (Update - 25.08.2022) (French, Pdf, 1.39 Mb)

Report on the effectiveness of vaccination against COVID-19 - focus on healthcare workers (French, Pdf, 880 Kb)

Report on the effectiveness of vaccination against COVID-19 in Luxembourg (Update - 31 March 2023) (French, Pdf, 1.21 Mb)

Pharmacovigilance

Report 1 COVID-19 - Monitoring Adverse Vaccine Events (16/04/2021) (French, Pdf, 1.08 Mb)

Report 2 COVID-19 - Monitoring Adverse Vaccine Events (14/05/2021) (French, Pdf, 836 Kb)

Report 3 COVID-19 - Monitoring Adverse Vaccine Events (16/06/2021) (French, Pdf, 1.09 Mb)

Report 4 COVID-19 - Monitoring Adverse Vaccine Events (14/07/2021) (French, Pdf, 1.73 Mb)

Report 5 COVID-19 - Monitoring Adverse Vaccine Events (17/09/2021) (French, Pdf, 1.76 Mb)

Report 6 COVID-19 - Monitoring Adverse Vaccine Events (15/10/2021) (French, Pdf, 1.21 Mb)

Report 7 COVID-19 - Monitoring Adverse Vaccine Events (18/11/2021) (French, Pdf, 1.21 Mb)

Report 8 COVID-19 - Monitoring Adverse Vaccine Events (17/12/2021) (French, Pdf, 797 Kb)

Report 9 COVID-19 - Monitoring Adverse Vaccine Events (21/01/2022) (French, Pdf, 844 Kb)

Report 10 COVID-19 - Monitoring Adverse Vaccine Events (11/02/2022) (French, Pdf, 1.25 Mb)

Report 11 COVID-19 - Monitoring Adverse Vaccine Events (13/04/2022) (French, Pdf, 1.26 Mb)

Report 12 COVID-19 - Monitoring Adverse Vaccine Events (22/06/2022) (French, Pdf, 834 Kb)

Report 13 COVID-19 - Monitoring Adverse Vaccine Events (04/08/2022) (French, Pdf, 1.27 Mb)

Report 14 COVID-19 - Monitoring Adverse Vaccine Events (18/10/2022) (French, Pdf, 1.24 Mb)

Report 15 COVID-19 - Monitoring Adverse Vaccine Events (06/12/2022) (French, Pdf, 1.27 Mb)

Report 16 COVID-19 - Monitoring Adverse Vaccine Events (23/03/2023) (French, Pdf, 931 Kb)

Report 17 COVID-19 - Monitoring Adverse Vaccine Events (02/08/2023) (French, Pdf, 1.19 Mb)

Summary of product characteristics and package leaflet

The vaccines utilized in Luxembourg to help preventing COVID-19 disease have been thoroughly assessed by the European Medicines Agency (EMA) and consequently been approved by the European Commission (EC).

To allow insight into all the information available for the vaccines, the EMA has published a set of important data pertaining to it, including the package leaflet. Following are the various links to the vaccines being distributed in Luxembourg. If you click on the links, you are directed to a dedicated product page on the EMA website. If you scroll down to the heading "Product Information" and click on the respective language (available in 24 different languages), a PDF opens in a new page. In this PDF, you will have access to the package leaflet by scrolling down to section ANNEX III B.

Biontech Pfizer / Comirnaty

Comirnaty | European Medicines Agency (europa.eu)

Moderna / Spikevax

Spikevax | European Medicines Agency (europa.eu)

AstraZeneca / Vaxzevria

Vaxzevria | European Medicines Agency (europa.eu)

JCOVDEN (previously COVID-19 Vaccine Janssen)

Jcovden | European Medicines Agency (europa.eu)

Novavax / Nuvaxovid

Nuvaxovid | European Medicines Agency (europa.eu)

Videos

Do you need help?

Play Youtube video, see caption below

Do you need help to make your vaccination appointment?

Play Youtube video, see caption below

Brauchen Sie Hilfe, um Ihren Impftermin zu vereinbaren?

Expert Q&A

Play Youtube video, see caption below

Expert Q&A: Prof. Dr. Dirk Brenner - #1 How does a vaccine help our immune system?

Play Youtube video, see caption below

Expert Q&A: Prof. Stephanie Kreis - #4-6 mRNA vaccines and mutations

Play Youtube video, see caption below

Expert Q&A: Prof. Stephanie Kreis - #7-9 clinical development of mRNA vaccines

Play Youtube video, see caption below

Expert Q&A: Dr. Anna Chioti - #12 Treatments against COVID-19 – 1/2

Play Youtube video, see caption below

Expert Q&A: Prof. Dr. Dirk Brenner - #3 Viral vector vaccines

Play Youtube video, see caption below

Expert Q&A: Prof. Stephanie Kreis - #1-3 mRNA vaccines

Play Youtube video, see caption below

Expert Q&A: Prof. Stephanie Kreis - #10 Explanation of the recombinant protein vaccine

Play Youtube video, see caption below

Expert Q&A: Dr. Anna Chioti - #13 Treatments against COVID-19 – 2/2

Webinars

Play Youtube video, see caption below

Webinar Vaccines - Dr. Anna Chioti and the Univsersity of Luxembourg (French)

Play Youtube video, see caption below

Webinar Vaccines - Dr. Anna Chioti and the Univsersity of Luxembourg

Live Meeting

Play Youtube video, see caption below

Dir frot. Mir äntwerten. (Luxembourgish)

Last update